Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates

被引:79
作者
Flashner, Y [1 ]
Mamroud, E [1 ]
Tidhar, A [1 ]
Ber, R [1 ]
Aftalion, M [1 ]
Gur, D [1 ]
Lazar, S [1 ]
Zvi, A [1 ]
Bino, T [1 ]
Ariel, N [1 ]
Velan, B [1 ]
Shafferman, A [1 ]
Cohen, S [1 ]
机构
[1] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel
关键词
D O I
10.1128/IAI.72.2.908-915.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In a search for novel attenuated vaccine candidates for use against Yersinia pestis, the causative agent of plague, a signature-tagged mutagenesis strategy was used and optimized for a subcutaneously infected mouse model. A library of tagged mutants of the virulent Y. pestis Kimberley53 strain was generated. Screening of 300 mutants through two consecutive cycles resulted in selection of 16 mutant strains that were undetectable in spleens 48 h postinfection. Each of these mutants was evaluated in vivo by assays for competition against the wild-type strain and for virulence following inoculation of 100 CFU (equivalent to 100 50% lethal doses [LD50] of the wild type). A wide spectrum of attenuation was obtained, ranging from avirulent mutants exhibiting competition indices of 10(-5) to 10(-7) to virulent mutants exhibiting a delay in the mean time to death or mutants indistinguishable from the wild type in the two assays. Characterization of the phenotypes and genotypes of the selected mutants led to identitication of virulence-associated genes coding for factors involved in global bacterial physiology (e.g., purH, purK, dnaE, and greA) or for hypothetical polypeptides, as well as for the virulence regulator gene lcrF. One of the avirulent mutant strains (LD50, > 10(7) CFU) was found to be disrupted in the pcm locus, which is presumably involved in the bacterial response to environmental stress. This Kimberley53pcm mutant was superior to the EV76 live vaccine strain because it induced 10- to 100-fold-higher antibody titers to the protective V and F1 antigens and because it conferred efficacious protective immunity.
引用
收藏
页码:908 / 915
页数:8
相关论文
共 49 条
[1]   Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice [J].
Anderson, GW ;
Heath, DG ;
Bolt, CR ;
Welkos, SL ;
Friedlander, AM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (06) :793-799
[2]   Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens [J].
Ariel, N ;
Zvi, A ;
Makarova, KS ;
Chitlaru, T ;
Elhanany, E ;
Velan, B ;
Cohen, S ;
Friedlander, AM ;
Shafferman, A .
INFECTION AND IMMUNITY, 2003, 71 (08) :4563-4579
[3]  
BAKER EE, 1952, J IMMUNOL, V68, P131
[4]   BACTERIOCIN-LIKE MATERIAL PRODUCED BY PASTEURELLA-PESTIS [J].
BENGURION, R ;
HERTMAN, I .
JOURNAL OF GENERAL MICROBIOLOGY, 1958, 19 (02) :289-+
[5]   ESSENTIAL VIRULENCE DETERMINANTS OF DIFFERENT YERSINIA SPECIES ARE CARRIED ON A COMMON PLASMID [J].
BENGURION, R ;
SHAFFERMAN, A .
PLASMID, 1981, 5 (02) :183-187
[6]   Development of an improved selective agar medium for isolation of Yersinia pestis [J].
Ber, R ;
Mamroud, E ;
Aftalion, M ;
Tidhar, A ;
Gur, D ;
Flashner, Y ;
Cohen, S .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (10) :5787-5792
[7]   ASSESSMENT OF A FLUOROQUINOLONE, 3 BETA-LACTAMS, 2 AMINOGLYCOSIDES, AND A CYCLINE IN TREATMENT OF MURINE YERSINIA-PESTIS INFECTION [J].
BONACORSI, SP ;
SCAVIZZI, MR ;
GUIYOULE, A ;
AMOUROUX, JH ;
CARNIEL, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :481-486
[8]   GREA PROTEIN - A TRANSCRIPTION ELONGATION-FACTOR FROM ESCHERICHIA-COLI [J].
BORUKHOV, S ;
POLYAKOV, A ;
NIKIFOROV, V ;
GOLDFARB, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :8899-8902
[9]  
BRUBAKER R R, 1970, Infection and Immunity, V1, P446
[10]   Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization [J].
Chiang, SL ;
Mekalanos, JJ .
MOLECULAR MICROBIOLOGY, 1998, 27 (04) :797-805